Metafuels secures a €1.92M Dutch government grant to accelerate development of an e-SAF plant in Rotterdam, boosting sustainable aviation fuel innovation in Europe.
Author: Elyse Christian
Alice & Bob lands major ARPA-E funding for next-gen magnets French quantum startup Alice & Bob has secured a €3.4 million award from the U.S. Department of Energy’s Advanced Research Projects Agency-Energy (ARPA-E) to accelerate the discovery of rare-earth-free permanent magnets using advanced quantum computing techniques. Tackling the rare-earth dependency in critical materials Permanent magnets are essential components in electric vehicles, wind turbines, consumer electronics and a wide range of industrial systems. Today, many of the highest-performance magnets rely on rare earth elements, a supply chain dominated by a small number of producing countries and exposed to price volatility, export…
UK startup Semarion secures £2.9M led by Parkwalk to scale its SemaCyte cell assay platform, aiming to cut time and cost in early-stage drug discovery.
New climate tech and AI tools are arming homeowners with real-time wildfire risk data, predictive insights and home-hardening solutions as fire seasons intensify.
Female leaders are reshaping AgriTech, but funding gaps, bias and tech access still slow their rise. Here’s where the real opportunities and obstacles lie.
European startup R3 Bio is betting on humane biotech, using advanced cell models to cut animal testing while speeding safer, more predictive drug discovery.
Utrecht-based Laigo Bio closes an extended seed round to advance protein degradation technologies for next-generation targeted therapies.
UK-based Dexory raises €9.8M to expand its autonomous warehouse robots and real-time data intelligence platform across Europe and global logistics hubs.
Berlin-based biotech startup Cellbricks secures €10M led by Silicon Roundabout to accelerate 3D-printed tissue implants and future organ replacement.
German biotech iDEL Therapeutics secures €9M to build a next‑generation cancer therapeutics platform targeting hard‑to‑treat tumors.